China-Outbound/U.S.-Inbound M&A

With the recent failed attempt by Anbang to obtain the required U.S. regulatory approvals to purchase Fidelity & Guaranty Life, this article provides insight into the U.S. insurance regulatory approval process and how Chinese and other foreign acquirers can navigate them successfully.

This article was first published in the July issue of Asia Insurance Review.